查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434877

苯磺酸氨氯地平市場：按類型、按應用分類 - 全球預測 2024-2030

Amlodipine Besylate Market by Type (10 mg Tablets, 2.5 mg Tablets, 5 mg Tablets), Application (Heart Diseases, High Blood Pressure) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

苯磺酸氨氯地平市場規模預估2023年為41,337萬美元，2024年達4,3728萬美元，預估2030年將達6,2905萬美元，複合年成長率為6.18%。

苯磺酸氨氯地平全球市場

主要市場統計
基準年[2023] 41337萬美元
預測年份 [2024] 43728萬美元
預測年份 [2030] 62905萬美元
複合年成長率（%） 6.18%
苯磺酸氨氯地平市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估苯磺酸氨氯地平市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對苯磺酸氨氯地平市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

苯磺酸1-氨氯地平市場的市場規模和預測是多少？

在2-苯磺酸氨氯地平市場預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3-苯磺酸氨氯地平市場的技術趨勢和法律規範是什麼？

4-苯磺酸氨氯地平市場主要供應商的市場佔有率是多少？

進入苯磺酸5-氨氯地平市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 高血壓和心臟病盛行率上升
      • 苯磺酸氨氯地平在各種治療的使用增加
      • 冠心病治療指出的實施
    • 抑制因素
      • 氨氯地平替代品的可用性
    • 機會
      • 新引入快速測試和照護現場診斷
      • 增加對苯磺酸氨氯地平研發活動的投資
    • 任務
      • 關於苯磺酸氨氯地平副作用的擔憂
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章苯磺酸氨氯地平市場：依類型

  • 10毫克片劑
  • 2.5毫克片劑
  • 5毫克片劑

第7章苯磺酸氨氯地平市場：依應用分類

  • 心臟疾病
  • 高血壓

第8章 苯磺酸氨氯地平北美、南美市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區苯磺酸氨氯地平市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲苯磺酸氨氯地平市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第12章競爭產品組合

  • 主要公司簡介
    • Apotex Inc.
    • Aurobindo Pharma Limited
    • Cadila Pharmaceuticals Limited
    • Century Pharmaceuticals Ltd.
    • Changzhou Yabang Pharmaceutical Co., Ltd.
    • Chartwell Pharmaceuticals LLC
    • Cipla Inc.
    • Dr. Reddys Laboratories Ltd.
    • Lupin Limited
    • MOEHS IBERICA, SL
    • Orbion Pharmaceuticals Private Limited
    • Pfizer Inc.
    • Sanofi SA
    • Strides Pharma Science Limited
    • Teva Pharmaceutical Industries Ltd.
  • 主要產品系列

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-742BD517AB12

[196 Pages Report] The Amlodipine Besylate Market size was estimated at USD 413.37 million in 2023 and expected to reach USD 437.28 million in 2024, at a CAGR 6.18% to reach USD 629.05 million by 2030.

Global Amlodipine Besylate Market

KEY MARKET STATISTICS
Base Year [2023] USD 413.37 million
Estimated Year [2024] USD 437.28 million
Forecast Year [2030] USD 629.05 million
CAGR (%) 6.18%
Amlodipine Besylate Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Amlodipine Besylate Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Amlodipine Besylate Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Amlodipine Besylate Market, highlighting leading vendors and their innovative profiles. These include Apotex Inc., Aurobindo Pharma Limited, Cadila Pharmaceuticals Limited, Century Pharmaceuticals Ltd., Changzhou Yabang Pharmaceutical Co., Ltd., Chartwell Pharmaceuticals LLC, Cipla Inc., Dr. Reddys Laboratories Ltd., Lupin Limited, MOEHS IBERICA, SL, Orbion Pharmaceuticals Private Limited, Pfizer Inc., Sanofi S.A., Strides Pharma Science Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Amlodipine Besylate Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • 10 mg Tablets
    • 2.5 mg Tablets
    • 5 mg Tablets
  • Application
    • Heart Diseases
    • High Blood Pressure
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Amlodipine Besylate Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Amlodipine Besylate Market?

3. What are the technology trends and regulatory frameworks in the Amlodipine Besylate Market?

4. What is the market share of the leading vendors in the Amlodipine Besylate Market?

5. Which modes and strategic moves are suitable for entering the Amlodipine Besylate Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Amlodipine Besylate Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of hypertension and heart diseases
      • 5.1.1.2. Increasing usage of amlodipine besylate in various treatments
      • 5.1.1.3. Implementation of guidelines for coronary artery disease treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative medications to amlodipine
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging adoption of rapid testing and point-of-care diagnosis
      • 5.1.3.2. Increasing investments in research and development activities of amlodipine besylate
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with side effects of amlodipine besylate
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Amlodipine Besylate Market, by Type

  • 6.1. Introduction
  • 6.2. 10 mg Tablets
  • 6.3. 2.5 mg Tablets
  • 6.4. 5 mg Tablets

7. Amlodipine Besylate Market, by Application

  • 7.1. Introduction
  • 7.2. Heart Diseases
  • 7.3. High Blood Pressure

8. Americas Amlodipine Besylate Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Amlodipine Besylate Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Amlodipine Besylate Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Apotex Inc.
    • 12.1.2. Aurobindo Pharma Limited
    • 12.1.3. Cadila Pharmaceuticals Limited
    • 12.1.4. Century Pharmaceuticals Ltd.
    • 12.1.5. Changzhou Yabang Pharmaceutical Co., Ltd.
    • 12.1.6. Chartwell Pharmaceuticals LLC
    • 12.1.7. Cipla Inc.
    • 12.1.8. Dr. Reddys Laboratories Ltd.
    • 12.1.9. Lupin Limited
    • 12.1.10. MOEHS IBERICA, SL
    • 12.1.11. Orbion Pharmaceuticals Private Limited
    • 12.1.12. Pfizer Inc.
    • 12.1.13. Sanofi S.A.
    • 12.1.14. Strides Pharma Science Limited
    • 12.1.15. Teva Pharmaceutical Industries Ltd.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. AMLODIPINE BESYLATE MARKET RESEARCH PROCESS
  • FIGURE 2. AMLODIPINE BESYLATE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AMLODIPINE BESYLATE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AMLODIPINE BESYLATE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AMLODIPINE BESYLATE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AMLODIPINE BESYLATE MARKET DYNAMICS
  • FIGURE 7. AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AMLODIPINE BESYLATE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. AMLODIPINE BESYLATE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AMLODIPINE BESYLATE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AMLODIPINE BESYLATE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. AMLODIPINE BESYLATE MARKET SIZE, BY 10 MG TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AMLODIPINE BESYLATE MARKET SIZE, BY 2.5 MG TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. AMLODIPINE BESYLATE MARKET SIZE, BY 5 MG TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. AMLODIPINE BESYLATE MARKET SIZE, BY HEART DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMLODIPINE BESYLATE MARKET SIZE, BY HIGH BLOOD PRESSURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. AMLODIPINE BESYLATE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 99. AMLODIPINE BESYLATE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. AMLODIPINE BESYLATE MARKET LICENSE & PRICING